Literature DB >> 24466405

The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.

Michelle A Camerino1, Nan Zhong2, Aiping Dong2, Bradley M Dickson1, Lindsey I James1, Brandi M Baughman1, Jacqueline L Norris1, Dmitri B Kireev1, William P Janzen1, Cheryl H Arrowsmith3, Stephen V Frye1.   

Abstract

We recently reported the discovery of UNC1215, a potent and selective chemical probe for the L3MBTL3 methyllysine reader domain. In this article, we describe the development of structure-activity relationships (SAR) of a second series of potent L3MBTL3 antagonists which evolved from the structure of the chemical probe UNC1215. These compounds are selective for L3MBTL3 against a panel of methyllysine reader proteins, particularly the related MBT family proteins, L3MBTL1 and MBTD1. A co-crystal structure of L3MBTL3 and one of the most potent compounds suggests that the L3MBTL3 dimer rotates about the dimer interface to accommodate ligand binding.

Entities:  

Year:  2013        PMID: 24466405      PMCID: PMC3897169          DOI: 10.1039/C3MD00197K

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  23 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 2.  Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails.

Authors:  Y Zhang; D Reinberg
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

Review 3.  Polycomb silencing mechanisms and the management of genomic programmes.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

4.  Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins.

Authors:  Tim J Wigle; J Martin Herold; Guillermo A Senisterra; Masoud Vedadi; Dmitri B Kireev; Cheryl H Arrowsmith; Stephen V Frye; William P Janzen
Journal:  J Biomol Screen       Date:  2009-12-11

5.  The art of the chemical probe.

Authors:  Stephen V Frye
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

6.  Unrestrained computation of free energy along a path.

Authors:  Bradley M Dickson; He Huang; Carol Beth Post
Journal:  J Phys Chem B       Date:  2012-08-30       Impact factor: 2.991

7.  Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment.

Authors:  M David Stewart; Jiwen Li; Jiemin Wong
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 8.  Readers of histone modifications.

Authors:  Miyong Yun; Jun Wu; Jerry L Workman; Bing Li
Journal:  Cell Res       Date:  2011-03-22       Impact factor: 25.617

9.  Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing.

Authors:  Gunnar Schotta; Anja Ebert; Veiko Krauss; Andreas Fischer; Jan Hoffmann; Stephen Rea; Thomas Jenuwein; Rainer Dorn; Gunter Reuter
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

10.  A novel de novo 1.1 Mb duplication of 17q21.33 associated with cognitive impairment and other anomalies.

Authors:  Farah R Zahir; Sylvie Langlois; Kim Gall; Patrice Eydoux; Marco A Marra; Jan M Friedman
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

View more
  7 in total

1.  The L3MBTL3 Methyl-Lysine Reader Domain Functions As a Dimer.

Authors:  Brandi M Baughman; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Stephen V Frye
Journal:  ACS Chem Biol       Date:  2015-09-02       Impact factor: 5.100

2.  Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family.

Authors:  Natalia Milosevich; Michael C Gignac; James McFarlane; Chakravarthi Simhadri; Shanti Horvath; Kevin D Daze; Caitlin S Croft; Aman Dheri; Taylor T H Quon; Sarah F Douglas; Jeremy E Wulff; Irina Paci; Fraser Hof
Journal:  ACS Med Chem Lett       Date:  2015-12-07       Impact factor: 4.345

3.  The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.

Authors:  Yupeng He; Sujatha Selvaraju; Michael L Curtin; Clarissa G Jakob; Haizhong Zhu; Kenneth M Comess; Bailin Shaw; Juliana The; Evelyne Lima-Fernandes; Magdalena M Szewczyk; Dong Cheng; Kelly L Klinge; Huan-Qiu Li; Marina Pliushchev; Mikkel A Algire; David Maag; Jun Guo; Justin Dietrich; Sanjay C Panchal; Andrew M Petros; Ramzi F Sweis; Maricel Torrent; Lance J Bigelow; Guillermo Senisterra; Fengling Li; Steven Kennedy; Qin Wu; Donald J Osterling; David J Lindley; Wenqing Gao; Scott Galasinski; Dalia Barsyte-Lovejoy; Masoud Vedadi; Fritz G Buchanan; Cheryl H Arrowsmith; Gary G Chiang; Chaohong Sun; William N Pappano
Journal:  Nat Chem Biol       Date:  2017-01-30       Impact factor: 15.040

4.  Discovery and development of potent and selective inhibitors of histone methyltransferase g9a.

Authors:  Ramzi F Sweis; Marina Pliushchev; Peter J Brown; Jun Guo; Fengling Li; David Maag; Andrew M Petros; Nirupama B Soni; Chris Tse; Masoud Vedadi; Michael R Michaelides; Gary G Chiang; William N Pappano
Journal:  ACS Med Chem Lett       Date:  2014-01-02       Impact factor: 4.345

Review 5.  Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.

Authors:  Nilesh Zaware; Ming-Ming Zhou
Journal:  Curr Opin Chem Biol       Date:  2017-07-06       Impact factor: 8.822

6.  A fast, open source implementation of adaptive biasing potentials uncovers a ligand design strategy for the chromatin regulator BRD4.

Authors:  Bradley M Dickson; Parker W de Waal; Zachary H Ramjan; H Eric Xu; Scott B Rothbart
Journal:  J Chem Phys       Date:  2016-10-21       Impact factor: 3.488

Review 7.  Chemical probes for methyl lysine reader domains.

Authors:  Lindsey I James; Stephen V Frye
Journal:  Curr Opin Chem Biol       Date:  2016-06-25       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.